SCHEMBL30914742

SCHEMBL30914742

CCCCCCCC(CCCCC)CCOC(=O)CCCCCCBr

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.61
TSHR P16473 2/20 0.51
DNM1 Q05193 1/20 0.51
CYP3A4 P08684 1/20 0.51
ATM Q13315 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 1/20 0.49
LMNA P02545 4/20 0.47
ALDH1A1 P00352 1/20 0.47
PAM P19021 2/20 0.47
KDM4E B2RXH2 1/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
PRKCA P17252 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22465777 1.00 DGKA (0.61) DGKATSHRDNM1CYP3A4ATM
SCHEMBL22465665 1.00 DGKA (0.61) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115477 1.00 DGKA (0.61) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115343 1.00 DGKA (0.61) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115475 0.98 DGKA (0.59) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115330 0.97 DGKA (0.57) DGKATSHRDNM1CYP3A4ATM
SCHEMBL31252975 0.95 DGKA (0.58) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115446 0.95 DGKA (0.58) DGKATSHRDNM1CYP3A4ATM
SCHEMBL38661027 0.94 DGKA (0.57) DGKATSHRDNM1CYP3A4ATM
SCHEMBL23115354 0.94 DGKA (0.61) DGKATSHRDNM1CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024205657-A2 LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES ORNA THERAPEUTICS, INC. (US) 2024-10-03 WO disclosed
WO-2024102730-A1 LIPIDS AND NANOPARTICLE COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES ORNA THERAPEUTICS, INC. (US) 2024-05-16 WO disclosed